LCTX logo
Lineage Cell Therapeutics, Inc.(LCTX)
Last print unknown agoAbout this dataData status
$0.95▼-0.03 (-2.61%)Stale · unknown old

LCTX CapEx to Operating CF

-0.52%TTM

Retrieved:

LCTX FY CapEx/OCF%
LCTX FY CapEx/OCF50.11%-64.71%
1992-06-302025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

LCTX capex to operating cf history

Capital expenditure as percentage of operating cash flow. The available annual fiscal periods series contains 34 observations from Jun 30, 1992 to Dec 31, 2025.

Lineage Cell Therapeutics, Inc. Common Stock CapEx to Operating CF — Annual fiscal periods
Period endingCapEx to Operating CF
-2.7591%
-2.4467%
-2.3594%
38.9991%
-1.5025%
-0.324%
-1.3773%
-10.6437%
-4.3451%
-5.968%
-11.9747%
-1.2434%
-7.717%
-2.0367%
-7.0751%
-5.6353%
-1.4384%
-53.5998%
-0.522%
-0.8449%
0%
0%
0%
-0.1799%
-0.1594%
-0.6877%
-3.6797%
0%
-7.6923%
0%
-5%
0%
0%
0%

Compare capex to operating cf

All LCTX financial metrics · LCTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.